Location History:
- Watertown, MA (US) (1982 - 1984)
- New York, NY (US) (1983 - 2017)
Company Filing History:
12 out of 712 
3 out of 504 
1 out of 1 Years Active: 1982-2017
Title: The Innovative Contributions of Michael A. Brownlee
Introduction: Michael A. Brownlee, a prominent inventor based in New York, NY, has made substantial contributions to the medical field, particularly through his research on hyperglycemia and fatty acid flux. With an impressive portfolio of 17 patents, Brownlee's work addresses critical health issues and offers innovative therapeutic methods.
Latest Patents: Among his latest patents are significant advancements in treating or preventing the pathologic effects of acute increases in hyperglycemia and free fatty acid flux. One notable patent describes a method involving the administration of a composition containing a therapeutically effective amount of a reactive oxygen species (ROS) inhibitor to subjects in need of treatment. Another patent outlines similar methods aimed at mitigating the pathologic sequelae of acute hyperglycemia, promoting neovascularization, and identifying compounds suitable for treating ROS-mediated injuries. These inventions highlight Brownlee's commitment to advancing medical therapies.
Career Highlights: Michael A. Brownlee has a distinguished career, with pivotal roles in esteemed research institutions such as The Rockefeller University and the Albert Einstein College of Medicine. His tenure in these organizations has provided him with a platform to conduct groundbreaking research that influences contemporary medicine.
Collaborations: Throughout his career, Brownlee has collaborated with respected professionals in his field, including Anthony Cerami and Peter C. Ulrich. These partnerships reflect his ability to work within interdisciplinary teams to drive innovation and further his research objectives.
Conclusion: Michael A. Brownlee's contributions to the field of medical science through his numerous patents and collaborations have marked him as a noteworthy inventor. His ongoing work continues to have a profound impact on the understanding and treatment of hyperglycemia-related conditions, showcasing the vital role of innovation in medicine.